ロード中...
A biologically competitive 21 days hypofractionation scheme with weekly concomitant boost in breast cancer radiotherapy feasibility acute sub-acute and short term late effects
BACKGROUND: Radiation therapy after lumpectomy is a standard part of breast conserving therapy for invasive breast carcinoma. The most frequently used schedule worldwide is 60 Gy in 30 fractions in 6 weeks, a time commitment that sporadically may dissuade some otherwise eligible women from undertaki...
保存先:
主要な著者: | , , , , , , , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
BioMed Central
2010
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3002362/ https://ncbi.nlm.nih.gov/pubmed/21092219 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1748-717X-5-111 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|